The goal of this project is to assess the impact of COVID19 vaccines in patients with multiple sclerosis treated with different immunomodulators.

Funding Agency


Project Reference

Project Members

Main Project Outcomes

S. Queirós, “Right ventricular segmentation in multi-view cardiac MRI using a unified U-net model”, in E. Puyol Antón et al. (eds) Statistical Atlases and Computational Models of the Heart. Multi-Disease, Multi-View, and Multi-Center Right Ventricular Segmentation in Cardiac MRI Challenge. STACOM 2021. Lecture Notes in Computer Science, vol 13131, pp. 287-295, Springer, Cham, 2022.

“Best Paper Award in the M&Ms-2 Challenge”, by M&Ms2 Challenge organizers and the Medical Image Computing and Computer Assisted Intervention (MICCAI) Society.

Main Project Outcomes

F. Ladeira, C. Nobrega, CI. Mendes, M. Salavisa, J. Cerqueira. “COVACiMS Study: SARS-CoV-2 vaccine effectiveness in patients with multiple sclerosis”. Selected oral presentation at the European Academy of Neurology Congress. Viena, Austria (2022)

F. Ladeira, C. Nobrega, J. Cerqueira, COVACiMS collaborators. “Breakthrough COVID after primary or booster vaccination in MS patients under disease modifying treatment”. Poster presentation at ECTRIMS. Amsterdam, The Netherlands (2022)